MedTech Solutions (WAR:MDT) Change In Receivables: zł-0.50 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:MDT MedTech Solutions SA WAR:MDT
39 GF Score
Price zł0.38
GF Value zł0.03
Valuation Significantly Overvalued
! 10 Warning Signs
View Full Analysis

What is MedTech Solutions Change In Receivables?

MedTech Solutions WAR:MDT -2.08% 39 Change In Receivables is zł-0.50 Mil as of Jun. 2026. GuruFocus rates WAR:MDT with a GF Score™ of 39/100 and a GF Value™ of zł0.03 (Significantly Overvalued). The stock has 10 warning signs investors should review.

MedTech Solutions's change in receivables for the quarter that ended in Jun. 2026 was zł0.36 Mil. It means MedTech Solutions's Accounts Receivable declined by zł0.36 Mil from Mar. 2026 to Jun. 2026 .

MedTech Solutions's change in receivables for the fiscal year that ended in Dec. 2025 was zł-0.70 Mil. It means MedTech Solutions's Accounts Receivable increased by zł0.70 Mil from Dec. 2024 to Dec. 2025 .

MedTech Solutions's Accounts Receivable for the quarter that ended in Jun. 2026 was zł0.57 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. MedTech Solutions's Days Sales Outstanding for the three months ended in Jun. 2026 was 7,456.43.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. MedTech Solutions's liquidation value for the three months ended in Jun. 2026 was zł-0.27 Mil.

MedTech Solutions  (WAR:MDT) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

MedTech Solutions's Days Sales Outstanding for the quarter that ended in Jun. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0.572/0.007*91
=7,456.43

2. In Ben Graham's calculation of liquidation value, MedTech Solutions's accounts receivable are only considered to be worth 75% of book value:

MedTech Solutions's liquidation value for the quarter that ended in Jun. 2026 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0.37-2.277+0.75 * 0.572+0.5 * 2.419
=-0.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedTech Solutions Change In Receivables Related Terms

MedTech Solutions Change In Receivables Historical Data

* Premium members only.

The historical data trend for MedTech Solutions's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedTech Solutions Change In Receivables Chart

MedTech Solutions Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.30 -0.02 0.01 -0.05 -0.70

MedTech Solutions Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 -0.99 0.50 -0.38 0.36
WAR:MDT
39GF Score
MedTech Solutions SA WAR:MDT
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MedTech Solutions Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł-0.50 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of zł-0.50 Mil mean?
MedTech Solutions (WAR:MDT) has a Change In Receivables of zł-0.50 Mil as of Jun. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for MedTech Solutions and its competitors.
Is MedTech Solutions' Change In Receivables too high?
MedTech Solutions' current Change In Receivables is zł-0.50 Mil. Overall, MedTech Solutions has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does MedTech Solutions' Change In Receivables compare to AMZN and BABA?
MedTech Solutions' Change In Receivables of zł-0.50 Mil can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Retail - Cyclical company?
A good Change In Receivables depends on the Retail - Cyclical industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for MedTech Solutions and its competitors. MedTech Solutions's current Change In Receivables is zł-0.50 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedTech Solutions stock overvalued right now?
Based on GuruFocus' analysis, MedTech Solutions (WAR:MDT) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.03, compared to a current price of zł0.38 — trading 1153.3% above its estimated fair value. The current Change In Receivables is zł-0.50 Mil. MedTech Solutions' overall GF Score™ is 39/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For MedTech Solutions (WAR:MDT), the current Change In Receivables is zł-0.50 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MedTech Solutions (WAR:MDT) Overvalued in 2026?

Based on GuruFocus' analysis, MedTech Solutions stock appears to be overvalued. The current stock price of zł0.38 is trading 1153.3% above its estimated GF Value™ of zł0.03. GuruFocus considers MedTech Solutions to be Significantly Overvalued.

Key valuation signals for WAR:MDT:

  • Change In Receivables: zł-0.50 Mil
  • GF Value™: zł0.03 vs. price of zł0.38 (1153.3% above fair value)
  • GF Score™: 39/100 with 10 warning signs

No single metric tells the full story. See the WAR:MDT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MedTech Solutions Business Description

Address Dluga 29, Warsaw, POL, 00-238
MedTech Solutions SA formerly E-shopping Group SA main activity is based on conducting business through its own e-shops that operate in the dropshipping sales model.
39GF Score

Get the complete analysis for WAR:MDT

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł0.38
Price
zł0.03
GF Value